These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1851694)

  • 1. Deglycosylation of alpha 1-proteinase inhibitor is impaired in the faeces of patients with active inflammatory bowel disease (Crohn's disease).
    Mizon C; el Yamani J; Colombel JF; Maes P; Balduyck M; Laine A; Cortot A; Tartar A; Mizon J
    Clin Sci (Lond); 1991 May; 80(5):517-23. PubMed ID: 1851694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple method for the measurement of different forms of alpha 1 proteinase inhibitor in the faeces of patients with Crohn's disease.
    el Yamani J; Soudan B; Mizon C; Colombel JF; Balduyck M; Cortot A; Mizon J
    Ann Clin Biochem; 1992 Jul; 29 ( Pt 4)():418-21. PubMed ID: 1642448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased faecal exoglycosidase activities identify a subset of patients with active Crohn's disease.
    el Yamani J; Mizon C; Capon C; Colombel JF; Fournet B; Cortot A; Mizon J
    Clin Sci (Lond); 1992 Oct; 83(4):409-15. PubMed ID: 1330402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative study of fecal alpha 1-proteinase inhibitor in normal subjects and patients with Crohn's disease.
    Mizon C; Becuwe C; Balduyck M; Colombel JF; Cortot A; Mizon J; Degand P
    Clin Chem; 1988 Nov; 34(11):2268-70. PubMed ID: 3263222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Qualitative study of fecal alpha-1-antitrypsin in patients with inflammatory digestive disease and patients with ileostomy].
    Colombel JF; Mizon C; Chekkouri N; Balduyck M; Chaussade S; Becuwe C; Degand P; Mizon J; Cortot A
    Gastroenterol Clin Biol; 1991; 15(4):301-5. PubMed ID: 2060740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural heterogeneity of faecal alpha 1 antitrypsin shown by immunoblot analysis in patients with Crohn's disease.
    Boege F; Fischbach W
    Gut; 1991 May; 32(5):496-9. PubMed ID: 2040471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal clearance of alpha 1-antitrypsin reflects disease activity and correlates with rapid turnover proteins in chronic inflammatory bowel disease.
    Miura S; Yoshioka M; Tanaka S; Serizawa H; Tashiro H; Asakura H; Tsuchiya M
    J Gastroenterol Hepatol; 1991; 6(1):49-52. PubMed ID: 1909193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fecal excretion and the clearance of alpha 1-antitrypsin in patients with Crohn's disease].
    López A; Hinojosa J; Miralles A; Primo J; Bermúdez JD
    Rev Esp Enferm Dig; 1993 Apr; 83(4):235-9. PubMed ID: 8494651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Crohn's disease activity and alpha 1-antitrypsin in faeces.
    Arndt B; Schürmann G; Betzler M; Herfarth C; Schmidt-Gayk H
    Lancet; 1992 Oct; 340(8826):1037. PubMed ID: 1357424
    [No Abstract]   [Full Text] [Related]  

  • 10. Isolation and characterization of the viscous, high-molecular-mass microbial carbohydrate fraction from faeces of healthy subjects and patients with Crohn's disease and the consequences for a therapeutic approach.
    Ruseler-van Embden JG; Van Lieshout LM; Binnema DJ; Hazenberg MP
    Clin Sci (Lond); 1998 Oct; 95(4):425-33. PubMed ID: 9748418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular form of faecal alpha 1 antitrypsin in patients with Crohn's disease.
    Mizon C; eL Yamani J; Mizon J; Colombel JF; Cortot A
    Gut; 1992 Apr; 33(4):572. PubMed ID: 1582608
    [No Abstract]   [Full Text] [Related]  

  • 12. [Initial personal experiences with alpha-1-antitrypsin determination in feces].
    Schwery S; Meyenberger C; Ammann R; Wirth HP
    Schweiz Med Wochenschr; 1995 Sep; 125(38):1783-7. PubMed ID: 7481635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteric protein loss measured by fecal alpha 1-antitrypsin clearance in the assessment of Crohn's disease activity: a study of children and adolescents.
    Griffiths AM; Drobnies A; Soldin SJ; Hamilton JR
    J Pediatr Gastroenterol Nutr; 1986; 5(6):907-11. PubMed ID: 3491890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal elastase reflects disease activity in active ulcerative colitis.
    Adeyemi EO; Hodgson HJ
    Scand J Gastroenterol; 1992; 27(2):139-42. PubMed ID: 1561528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Initial clinical experiences with a simplified analytic method for fecal alpha-1-antitrypsin].
    Fischbach W; Deubel M; Boege F; Mössner J
    Z Gastroenterol; 1991 Dec; 29(12):650-4. PubMed ID: 1771947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease.
    Karbach U; Ewe K; Bodenstein H
    Gut; 1983 Aug; 24(8):718-23. PubMed ID: 6603392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal alpha 1-antitrypsin excretion in young people with Crohn's disease.
    Thomas DW; Sinatra FR; Merritt RJ
    J Pediatr Gastroenterol Nutr; 1983; 2(3):491-6. PubMed ID: 6604798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal excretion of alpha 1-antitrypsin in patients with Crohn's disease. A comparison of nephelometry and radial immunodiffusion.
    López A; Hinojosa J; Miralles A; Primo J; Bermúdez JD
    Dig Dis Sci; 1994 Mar; 39(3):507-12. PubMed ID: 8131686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
    Becker K; Niederau C; Frieling T
    Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical markers and MR imaging findings as predictors of crohn disease activity in patients scanned by contrast-enhanced MR enterography.
    Quaia E; Cabibbo B; Sozzi M; Gennari AG; Pontello M; Degrassi F; Cova MA
    Acad Radiol; 2014 Oct; 21(10):1225-32. PubMed ID: 24998692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.